Adeline Jacquinet

Adeline Jacquinet

Auto-generated profile, based on publicly available information

Adeline Jacquinet

GIGA-Human Genetics Laboratory, University of Liège, Liège, Belgium.

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2020 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
AJAdeline Jacquinet
Adeline Jacquinet
BBBouchra Boujemla
Bouchra Boujemla
CFCorinne Fasquelle
Corinne Fasquelle
JTJerôme Thiry
Jerôme Thiry
CJClaire Josse
Claire Josse
VBVincent Bours
Vincent Bours

Verified
Journal Article
Open access
PDF file
ALAimé Zola Lumaka
Aimé Zola Lumaka
CFCorinne Fasquelle
Corinne Fasquelle
FDFrançois-Guillaume Debray
François-Guillaume Debray
SASerpil Alkan
Serpil Alkan
AJAdeline Jacquinet
Adeline Jacquinet
VBVincent Bours
Vincent Bours
Rapid Whole Genome Sequencing (rWGS) represents a valuable exploration in critically ill pediatric patients. Early diagnosis allows care to be adjusted. We evaluated the feasibility, turnaround time (TAT), yield, and utility of rWGS in Belgium. Twenty-one unrelated critically ill patients were recruited from the neonatal intensive care units, the pediatric intensive care unit, and the neuropediatric unit, and offered rWGS as a first tier test. Libraries were prepared in the laboratory of human genetics of the University of Liège using Illumina DNA PCR-free protocol. Sequencing was performed on a NovaSeq 6000 in trio for 19 and in duo for two probands. The TAT was calculated from the sample reception to the validation of results. Clinical utility data were provided by treating physicians. A definite diagnosis was reached in twelve (57.5%) patients in 39.80 h on average (range: 37.05–43.7). An unsuspected diagnosis was identified in seven patients. rWGS guided care adjustments in diagnosed patients, including a gene therapy, an off-label drug trial and two condition-specific treatments. We successfully implemented the fastest rWGS platform in Europe and obtained one of the highest rWGS yields. This study establishes the path for a nationwide semi-centered rWGS network in Belgium.

27 December 2020 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
NGNicolas Rive Le Gouard
Nicolas Rive Le Gouard
AJAdeline Jacquinet
Adeline Jacquinet
LRLyse Ruaud
Lyse Ruaud
HDHélène Deleersnyder
Hélène Deleersnyder
FAFaustine Ageorges
Faustine Ageorges
AVAlain Verloes
Alain Verloes

10 January 2025 in medRxiv
Verified
Preprint
Open access
PDF file
AJAdeline Jacquinet
Adeline Jacquinet
LFLydie Flasse
Lydie Flasse
MDManon Dohet
Manon Dohet
RVRomane Vanhaeren
Romane Vanhaeren
HPHélène Pendeville
Hélène Pendeville
BPBernard Peers
Bernard Peers
The underlying cause for renal and uterine agenesis remains unknown in many cases, whereas recurrence in some families strongly suggests the involvement of genetic factors. Here, we identify 5 affected individuals from 3 families with phenotypes including bilateral or unilateral renal agenesis/hypoplasia, along with variable congenital uterine anomalies and costovertebral defects associated with heterozygous deleterious variants in NR6A1 . The variant spectrum includes both inherited missense as well as de novo loss of function, with the latter associated with a perinatal lethal phenotype characterized by bilateral renal agenesis. In vitro studies demonstrated partial loss-of-function for both missense variants. To investigate the role of NR6A1 in development, CRISPR-Cas9 knockout zebrafish models targeting the orthologues nr6a1a and nr6a1b were generated. Mutants recapitulate the human phenotype, exhibiting impaired kidney development, including pronephros segmentation defects and adult kidney hypoplasia, along with axial skeletal abnormalities, cloacal anomalies, and disrupted anteroposterior expression of posterior hox genes. This study provides strong evidence linking NR6A1 heterozygous loss-of-function variants to renal, uterine and costovertebral defects in humans.

24 February 2026 in Human Genetics
Verified
Journal Article
Closed access
PDF file
AJAdeline Jacquinet
Adeline Jacquinet
LFLydie Flasse
Lydie Flasse
MDManon Dohet
Manon Dohet
RVRomane Vanhaeren
Romane Vanhaeren
HPHélène Pendeville
Hélène Pendeville
BPBernard Peers
Bernard Peers

13 April 2026 in Human Genetics
Verified
Journal Article
Closed access
AJAdeline Jacquinet
Adeline Jacquinet
LFLydie Flasse
Lydie Flasse
MDManon Dohet
Manon Dohet
RVRomane Vanhaeren
Romane Vanhaeren
HPHélène Pendeville
Hélène Pendeville
BPBernard Peers
Bernard Peers